Airsculpt Technologies, INC. (AIRS) — SEC Filings

Q: What are the key financial highlights for Airsculpt Technologies, INC.?

Key financial highlights for Airsculpt Technologies, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Airsculpt Technologies, INC.?

Key executives at Airsculpt Technologies, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Airsculpt Technologies, INC. stock?

Risk factors for Airsculpt Technologies, INC. (AIRS) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Airsculpt Technologies, INC.?

Forward-looking statements and predictions from Airsculpt Technologies, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Airsculpt Technologies, INC.. Recent 8-K/A filing on Apr 6, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Airsculpt Technologies, INC. on SEC EDGAR

Overview

Airsculpt Technologies, INC. (AIRS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K/A filed on Apr 6, 2026: AirSculpt Technologies, Inc. filed an amendment (8-K/A) on April 6, 2026, to its previous filing related to its results of operations and financial condition for the period ending April 2, 2026. The amendment includes financial statements and exhibits, specifically referencing a document dated Decem

Sentiment Summary

Across 27 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 25 neutral. The dominant filing sentiment for Airsculpt Technologies, INC. is neutral.

Filing Type Overview

Airsculpt Technologies, INC. (AIRS) has filed 1 8-K/A, 1 10-K/A, 14 8-K, 5 10-Q, 2 DEF 14A, 2 10-K, 2 SC 13G/A with the SEC between Feb 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (27)

AirSculpt Amends Financial Filing — 8-K/A · Apr 6, 2026 Risk: low
AirSculpt Technologies, Inc. filed an amendment (8-K/A) on April 6, 2026, to its previous filing related to its results of operations and financial condition fo
AirSculpt Files 2025 Annual Report Amendment — 10-K/A · Apr 6, 2026 Risk: low
AirSculpt Technologies, Inc. filed an amendment (10-K/A) to its annual report on April 6, 2026, for the fiscal year ending December 31, 2025. The filing include
AirSculpt Technologies Files 8-K for Financial Results — 8-K · Apr 2, 2026 Risk: low
AirSculpt Technologies, Inc. filed an 8-K on April 2, 2026, reporting results of operations and financial condition for the period ending March 31, 2026. The fi
8-K Filing — 8-K · Nov 18, 2025
Airsculpt's Q3 Losses Widen Amid Revenue Drop, London Closure — 10-Q · Nov 7, 2025 Risk: high
Airsculpt Technologies, Inc. (AIRS) reported a significant decline in financial performance for the three and nine months ended September 30, 2025. Revenue decr
8-K Filing — 8-K · Nov 5, 2025
Airsculpt Soars: Q2 Revenue Jumps 17.4%, Net Income Up 52.9% — 10-Q · Aug 1, 2025 Risk: medium
Airsculpt Technologies, Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $45.2 million, up from $38.5 million
AirSculpt Technologies Enters Material Agreement — 8-K · Jun 11, 2025 Risk: medium
AirSculpt Technologies, Inc. announced on June 9, 2025, the entry into a material definitive agreement. The company also reported other events and filed financi
AirSculpt Technologies Files 8-K on Shareholder Votes & Financials — 8-K · May 8, 2025 Risk: low
AirSculpt Technologies, Inc. filed an 8-K on May 8, 2025, reporting on matters submitted to a vote of security holders and filing financial statements and exhib
AirSculpt Technologies Q1 2025 10-Q Filing — 10-Q · May 2, 2025 Risk: low
AirSculpt Technologies, Inc. filed its quarterly report for the period ending March 31, 2025. The filing includes financial data and operational details for the
AirSculpt Files 2024 Proxy Statement — DEF 14A · Mar 28, 2025 Risk: low
AirSculpt Technologies, Inc. filed its definitive proxy statement (DEF 14A) on March 28, 2025, for the fiscal year ending December 31, 2024. The filing provides
AirSculpt Technologies Files 2024 10-K — 10-K · Mar 14, 2025 Risk: medium
AirSculpt Technologies, Inc. filed its 2024 10-K report on March 14, 2025, detailing its fiscal year ending December 31, 2024. The company, headquartered in Mia
AirSculpt Technologies Files 8-K on Financials — 8-K · Jan 13, 2025 Risk: low
AirSculpt Technologies, Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing includes financial sta
AirSculpt Appoints New CFO, Grants Stock Options — 8-K · Dec 26, 2024 Risk: medium
AirSculpt Technologies, Inc. announced on December 20, 2024, the appointment of David M. Ryser as Chief Financial Officer, effective December 23, 2024. Ryser wi
AirSculpt Appoints Dr. Michael L. Brown as CMO — 8-K · Dec 17, 2024 Risk: low
AirSculpt Technologies, Inc. announced on December 16, 2024, the appointment of Dr. Michael L. Brown as Chief Medical Officer, effective immediately. Dr. Brown,
SC 13G/A Filing — SC 13G/A · Nov 8, 2024
AirSculpt Technologies Files Q3 2024 10-Q — 10-Q · Nov 8, 2024 Risk: medium
AirSculpt Technologies, Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the year.
AirSculpt Technologies Files 8-K on Financials — 8-K · Oct 24, 2024 Risk: low
AirSculpt Technologies, Inc. filed an 8-K on October 24, 2024, reporting on its results of operations and financial condition. The filing includes financial sta
AirSculpt Technologies Enters Material Definitive Agreement — 8-K · Sep 13, 2024 Risk: medium
AirSculpt Technologies, Inc. announced on September 13, 2024, that it entered into a Material Definitive Agreement. The filing does not provide specific details
AirSculpt Appoints New Chief Medical Officer — 8-K · Aug 9, 2024 Risk: low
AirSculpt Technologies, Inc. announced on August 8, 2024, the appointment of Dr. Michael R. Brown as Chief Medical Officer. Dr. Brown brings extensive experienc
AirSculpt Technologies Files 8-K for Financial Updates — 8-K · Aug 9, 2024 Risk: low
AirSculpt Technologies, Inc. filed an 8-K on August 9, 2024, to report on its results of operations and financial condition, as well as to file financial statem
AirSculpt Technologies Enters Material Definitive Agreement — 8-K · Aug 2, 2024 Risk: medium
On July 30, 2024, AirSculpt Technologies, Inc. entered into a Material Definitive Agreement. The filing does not provide specific details about the agreement or
Airsculpt Technologies, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024 Risk: low
Airsculpt Technologies, Inc. (AIRS) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Airsculpt Technologies, Inc. filed a 10-Q report for the perio
AirSculpt Technologies Files 8-K — 8-K · May 8, 2024 Risk: low
AirSculpt Technologies, Inc. filed an 8-K on May 8, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing deta
AirSculpt Technologies, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Mar 27, 2024 Risk: low
Airsculpt Technologies, Inc. (AIRS) filed a Proxy Statement (DEF 14A) with the SEC on March 27, 2024. The 2024 Annual Meeting of Stockholders for AirSculpt Tech
Airsculpt Technologies, Inc. Files 2023 Annual Report (10-K) — 10-K · Feb 27, 2024 Risk: low
Airsculpt Technologies, Inc. (AIRS) filed a Annual Report (10-K) with the SEC on February 27, 2024. Airsculpt Technologies, Inc. filed its 2023 10-K report on F
SC 13G/A Filing — SC 13G/A · Feb 14, 2024

Risk Profile

Risk Assessment: Of AIRS's 23 recent filings, 1 were flagged as high-risk, 7 as medium-risk, and 15 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Airsculpt Technologies, INC.'s most recent 10-Q filing (Nov 7, 2025):

Revenue: $34.993M
Net Income: $(9.512)M
EPS: $(0.15)
Debt-to-Equity: 1.26
Cash Position: $5.405M
Operating Margin: -27.86%
Total Assets: $185.920M
Total Debt: $56.913M

Key Executives

David M. Ryser
Dr. Michael L. Brown
Dr. Michael R. Brown
Todd Magazine

Industry Context

The aesthetic surgery market, particularly the weight loss segment, is experiencing intense competition. The rise of new weight-loss drugs poses a significant disruptive threat, potentially diverting demand from surgical procedures. Companies in this space must innovate and differentiate to maintain market share and patient volume.

Top Tags

financial-reporting (5) · filing (4) · 8-k (3) · 10-Q (3) · financials (3) · executive-appointment (3) · amendment (2) · annual-report (2) · corporate-governance (2) · quarterly-report (2)

Key Numbers

CIK Number: 0001870940 — Unique identifier for AirSculpt Technologies, Inc.
Fiscal Year End: 2025-12-31 — The period covered by the annual report.
SEC Accession Number: 0001870940-26-000016 — Unique identifier for this specific filing
Revenue for Q3 2025: $34.993M — Decreased by 17.75% from $42.548M in Q3 2024
Revenue for nine months ended Sept 30, 2025: $118.376M — Decreased by 16.01% from $141.172M in the prior year
Net loss for Q3 2025: $(9.512)M — Increased by 57.48% from $(6.040)M in Q3 2024
Net loss for nine months ended Sept 30, 2025: $(12.950)M — Increased by 302.55% from $(3.217)M in the prior year
Loss on impairment of long-lived assets in Q3 2025: $7.137M — Includes $4.6M for Salesforce project and $2.3M for London facility
Total assets as of Sept 30, 2025: $185.920M — Decreased from $209.996M at Dec 31, 2024
Total liabilities as of Sept 30, 2025: $103.815M — Decreased from $130.706M at Dec 31, 2024
Cash and cash equivalents as of Sept 30, 2025: $5.405M — Decreased from $8.235M at Dec 31, 2024
Shares of common stock outstanding as of Nov 6, 2025: 62,436,670 — Reflects recent share count
Q2 2025 Revenue: $45.2M — Increased 17.4% from $38.5M in Q2 2024
Q2 2025 Net Income: $7.8M — Increased 52.9% from $5.1M in Q2 2024
YTD 2025 Revenue: $88.9M — Increased 18.4% from $75.1M in YTD 2024

Related Companies

VCEL · INMD

Frequently Asked Questions

What are the latest SEC filings for Airsculpt Technologies, INC. (AIRS)?

Airsculpt Technologies, INC. has 27 recent SEC filings from Feb 2024 to Apr 2026, including 14 8-K, 5 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of AIRS filings?

Across 27 filings, the sentiment breakdown is: 1 bullish, 1 bearish, 25 neutral. The dominant sentiment is neutral.

Where can I find Airsculpt Technologies, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Airsculpt Technologies, INC. (AIRS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Airsculpt Technologies, INC.?

Key financial highlights from Airsculpt Technologies, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for AIRS?

The investment thesis for AIRS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Airsculpt Technologies, INC.?

Key executives identified across Airsculpt Technologies, INC.'s filings include David M. Ryser, Dr. Michael L. Brown, Dr. Michael R. Brown, Todd Magazine.

What are the main risk factors for Airsculpt Technologies, INC. stock?

Of AIRS's 23 assessed filings, 1 were flagged high-risk, 7 medium-risk, and 15 low-risk.

What are recent predictions and forward guidance from Airsculpt Technologies, INC.?

Forward guidance and predictions for Airsculpt Technologies, INC. are extracted from SEC filings as they are enriched.